| Profile of and risk factors for poststroke cognitive impairment in diverse ethnoregional groups JW Lo, JD Crawford, DW Desmond, O Godefroy, H Jokinen, S Mahinrad, ... Neurology 93 (24), e2257-e2271, 2019 | 230 | 2019 |
| Resting heart rate, heart rate variability and functional decline in old age G Ogliari, S Mahinrad, DJ Stott, JW Jukema, SP Mooijaart, PW Macfarlane, ... Cmaj 187 (15), E442-E449, 2015 | 103 | 2015 |
| Cognitive impairment and risk of stroke: a systematic review and meta-analysis of prospective cohort studies S Rostamian, S Mahinrad, T Stijnen, B Sabayan, AJM De Craen Stroke 45 (5), 1342-1348, 2014 | 103 | 2014 |
| 10-Second heart rate variability and cognitive function in old age S Mahinrad, JW Jukema, D Van Heemst, PW Macfarlane, EN Clark, ... Neurology 86 (12), 1120-1127, 2016 | 96 | 2016 |
| Cumulative blood pressure exposure during young adulthood and mobility and cognitive function in midlife S Mahinrad, S Kurian, CR Garner, S Sedaghat, AJ Nemeth, N Moscufo, ... Circulation 141 (9), 712-724, 2020 | 94 | 2020 |
| Hypertension and cognitive dysfunction: a review of mechanisms, life-course observational studies and clinical trial results S Mahinrad, FA Sorond, PB Gorelick Reviews in Cardiovascular Medicine 22 (4), 1429-1449, 2021 | 33 | 2021 |
| Natriuretic peptides in the central nervous system: novel targets for cognitive impairment S Mahinrad, AJM de Craen, S Yasar, D van Heemst, B Sabayan Neuroscience & Biobehavioral Reviews 68, 148-156, 2016 | 32 | 2016 |
| Left ventricular hypertrophy and cognitive decline in old age S Mahinrad, AE Vriend, JW Jukema, D Van Heemst, N Sattar, GJ Blauw, ... Journal of Alzheimer’s Disease 58 (1), 275-283, 2017 | 25 | 2017 |
| Spatial QRS-T angle and cognitive decline in older subjects S Mahinrad, I Ferguson, PW Macfarlane, EN Clark, DJ Stott, I Ford, ... Journal of Alzheimer’s Disease 67 (1), 279-289, 2019 | 17 | 2019 |
| Natriuretic peptides in post-mortem brain tissue and cerebrospinal fluid of non-demented humans and Alzheimer’s disease patients S Mahinrad, M Bulk, I Van der Velpen, A Mahfouz, W van Roon-Mom, ... Frontiers in Neuroscience 12, 864, 2018 | 17 | 2018 |
| Blood pressure variability, dementia, and role of antihypertensive medications in older adults S Mahinrad, DA Bennett, FA Sorond, PB Gorelick Alzheimer's & Dementia 19 (7), 2966-2974, 2023 | 15 | 2023 |
| The 2022 symposium on dementia and brain aging in low‐and middle‐income countries: Highlights on research, diagnosis, care, and impact R Kalaria, G Maestre, S Mahinrad, DM Acosta, RO Akinyemi, S Alladi, ... Alzheimer's & dementia 20 (6), 4290-4314, 2024 | 13 | 2024 |
| Vascular health and diffusion properties of normal appearing white matter in midlife C Ingo, S Kurian, J Higgins, S Mahinrad, L Jenkins, P Gorelick, ... Brain Communications 3 (2), fcab080, 2021 | 11 | 2021 |
| 4C. 03: short-term heart rate variability and cognitive function in older subjects at risk of cardiovascular disease S Mahinrad, D Van Heemst, PW Macfarlane, DJ Stott, JW Jukema, ... Journal of Hypertension 33, e57, 2015 | 11 | 2015 |
| The role of vascular risk factors in cognitive impairment and dementia and prospects for prevention S Mahinrad, F Sorond, PB Gorelick Clinics in geriatric medicine 39 (1), 123, 2022 | 9 | 2022 |
| Intracranial Blood Flow Quantification by Accelerated Dual‐venc 4D Flow MRI: Comparison With Transcranial Doppler Ultrasound S Mahinrad, CO Tan, Y Ma, M Aristova, AL Milstead, D Lloyd‐Jones, ... Journal of Magnetic Resonance Imaging 56 (4), 1256-1264, 2022 | 9 | 2022 |
| Vascular health across young adulthood and midlife cerebral autoregulation, gait, and cognition S Mahinrad, M Shownkeen, S Sedaghat, K Yaffe, JM Hausdorff, ... Alzheimer's & Dementia 17 (5), 745-754, 2021 | 9 | 2021 |
| Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference CM Kloske, ME Belloy, EE Blue, GR Bowman, MC Carrillo, X Chen, ... Alzheimer's & Dementia, 2024 | 6 | 2024 |
| N‐terminal pro brain, N‐terminal pro atrial natriuretic peptides, and dynamic cerebral autoregulation S Mahinrad, B Sabayan, CR Garner, DM Lloyd‐Jones, FA Sorond Journal of the American Heart Association 9 (20), e018203, 2020 | 3 | 2020 |
| Benefits and risks of FDA‐approved amyloid‐targeting antibodies for treatment of early Alzheimer's disease: Navigating clinician‐patient engagement DM Rentz, PS Aisen, A Atri, J Hitchcock, M Irizarry, J Landen, ... Alzheimer's & Dementia 20 (11), 8162-8171, 2024 | 1 | 2024 |